YHLO at MEDICA 2026: New Product Matrix Debut & Global Partners Exchange Meeting


On November 16 local time, the global healthcare industry event MEDICA 2026 opened in Düsseldorf, Germany. 

As a long-term exhibitor at MEDICA, YHLO presented its innovative products and holistic solutions across multiple fields at the exhibition, and hosted the 2026 Global Core Partners Exchange Meeting that evening. Partners from around the world gathered together to exchange views on products, technologies, and markets in areas such as autoimmune diseases, cardiovascular diseases, and laboratory automation, and to share innovative achievements and market experience.

Day One of the Exhibition: Innovative Products and Diagnostic Solutions on Display

 

As a key industry exhibition in the global healthcare sector, MEDICA brings together medical enterprises, industry experts, and professionals from around the world, building an important platform for international exchange and cooperation. On the first day of the exhibition, YHLO's booth attracted many professional visitors. At the booth, YHLO's IFA platform and multiplex detection platform made their debut in the international market. 

Together with the iTLA mini Plus, which combines compact design with intelligent management advantages, they formed a fully automated autoimmune testing system, jointly showcasing a holistic solution for autoimmune diseases covering the entire process of screening, diagnosis, and monitoring. At the same time, products from multiple technology platforms, including the iFlash series and Tenfly Phoenix, were also exhibited. YHLO's international team met face to face with customers, experts, and industry partners from different countries and regions. They exchanged views on product features, clinical applications, and market demands. 

The discussions deepened mutual understanding of how products and solutions can better meet user needs.

Technology Sharing: Core Partners Exchange Meeting Held

 

On the evening of November 16, the YHLO 2026 Global Core Partners Exchange Meeting took place as scheduled. In-depth exchanges were held with global partners focusing on key products, clinical applications, and cutting-edge scientific research findings.

Autoimmunity: 

In the autoimmunity thematic session, the holistic solution for autoimmune diseases covering the entire process of screening, diagnosis, and monitoring was highlighted. Relying on the IFA, LIA, CLIA, and multiplex detection technology platforms, it covers multiple areas of autoimmune diseases and provides multi-dimensional support for the precise detection of related diseases. 

At the same time, YHLO's scientific research and academic progress in the field of autoimmune disease diagnosis were introduced, including: 

  • Refractory Autoimmune Diseases: Precision Diagnosis & Innovative Therapies
  • Chinese AntiphosPholipid Syndrome cohorT cOllaborative NEtworks (CAPSTONE)
  • The construction of an AI-based indirect immunofluorescence (IIF) morphology database for autoimmune diseases

Cardiovascular Disease:

The cardiovascular biomarker session focused on clinically relevant cardiovascular testing items. It highlighted a detection portfolio centered on high-sensitivity cardiac troponin (hs-cTnI). The portfolio also covers multiple testing items, including NT-proBNP, BNP, sST2, D-dimer, myoglobin, cardiac troponin I, and CK-MB. Together, these offerings demonstrate YHLO's product layout and technological advantages in the cardiovascular disease field. They also provide more testing options for clinical auxiliary diagnosis and disease management.

Allergen Testing:

In the allergen thematic session, the team introduced YHLO's allergen testing-related products and technologies, showcasing the company's product layout in the allergen testing field as well as testing solutions for different clinical needs.

After the thematic sessions, the attending guests engaged in lively and in-depth free exchanges. Subsequently, all guests took a group photo and attended the dinner together.

Joining Hands with Global Partners on a New Journey

Every gathering is a new exchange; Every sharing opens up more possibilities for cooperation. 

This series of exhibitions and exchanges not only enabled global partners to further understand YHLO's continuously deepening layout in advantageous fields such as autoimmune disease diagnosis and cardiac biomarkers, but also allowed both sides to enhance trust and deepen connections through exchanges.

In the future, YHLO looks forward to continuing to walk side by side with global partners, carrying out more exchanges and cooperation in technological innovation, clinical evidence and application, and market opportunities, and jointly advancing the development of the in vitro diagnostics industry.

Attachments:


MORE NEWS


YHLO at MEDICA 2026: New Product Matrix Debut & Global Partners Exchange Meeting


YHLO unveiled a new product matrix at MEDICA 2026 and strengthened global partnerships at its Core Partners Exchange Meeting.

2026-11-20

China-Hospeq 2026: YHLO Brings Diagnostic Solutions to Global Health Partners


YHLO Brings Diagnostic Solutions to Global Health Partners at China-Hospeq 2026

2026-08-20